Executive record
Bruce Car, Ph.D.
Public governance roles and source-backed Claims for this individual.
More
Alpha ID: alpha:person:bruce-car-ph-d-bhvnVersion: public-0As of: 2026-10-03
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
Biography
Joined as Chief Scientific Officer in 2022, previously served as Chief Scientific Officer at Agios Pharmaceuticals and spent 25 years at BMS where he built a translational medicine team of over 300 scientists covering biomarkers through data science, contributing to approximately 250 drug candidates and over 18 drug registrations.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Board service
Board service coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageExecutive career
- Dates not publishedExecutive title: Chief Scientific Officer · Organization not publishedBHVN executive roster source
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
1 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
BHVN executive roster source
sec filing · Source published: Date unavailable · Retrieved: May 3, 2026
Supports 5 claims
- AI expertise: AI expertise reported in filings · Claim reviewed: May 3, 2026
- AI governance relevance: AI governance relevance reported from role and filings · Claim reviewed: May 3, 2026
- Executive company: Executive at Biohaven Ltd. · Claim reviewed: May 3, 2026
- Executive function: Other Executive (OTHER_EXECUTIVE) · Claim reviewed: May 3, 2026
- Executive title: Executive title: Chief Scientific Officer · Claim reviewed: May 3, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03
- Biography
- published
- Board service
- not observed
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope